Dispensing errors for pediatric orders are particularly perilous and can be partially explained by the relative lack of education pharmacists receive regarding medications and children. Pharmacists ...
A new study conducted by University Hospitals Connor Whole Health highlights the impact of pediatric integrative medicine ...
The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...
The U.S. Food and Drug Administration (FDA) has granted rare pediatric drug designation for iopofosine-131 in inoperable relapsed or refractory pediatric high-grade glioma (pHGG), according to a news ...
PolyActiva and RareSight collaborate to create innovative therapies for rare pediatric retinal diseases, aiming to transform ...
CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression Free Survival and Overall Survival ...
Medication errors among pediatric cancer patients are more common when medicine is administered at home than at the hospital, according to a study in Pediatrics. Researchers observed medication ...
New research from the University of Alabama at Birmingham suggests that young patients with acute lymphocytic leukemia, or ALL — the most common type of pediatric cancer — and their parents are likely ...
Cost-Effectiveness of Oral Levofloxacin Versus Amoxicillin-Clavulanate/Ciprofloxacin for Outpatient Management of Low-Risk Febrile Neutropenia in Children With Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback